Probio-M9 has been demonstrated to enhance tumor suppression in a manner dependent on anti-PD-1, through the generation of advantageous metabolites, the encouragement of CTL infiltration and stimulation, and the curtailment of Treg cell function within the TME (67). The gene discussed is PDCD1; the disease is neoplasm.